PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

PAR. SP, page-516

  1. 333 Posts.
    lightbulb Created with Sketch. 93
    According to Beverley Huttmans slides in AGM , 10% OA penetration for knee in the world is 27 billion.

    That’s based off pricing not being a DMOAD Label (which it clearly is).

    My feel is once 2mg twice weekly is ticked off, deals will be written
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.